A detailed history of Brevan Howard Capital Management LP transactions in Viatris Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 57,909 shares of VTRS stock, worth $742,972. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,909
Previous 105,081 44.89%
Holding current value
$742,972
Previous $1.12 Million 39.84%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.32 - $12.13 $486,815 - $572,196
-47,172 Reduced 44.89%
57,909 $672,000
Q2 2024

Aug 14, 2024

BUY
$10.05 - $12.02 $820,984 - $981,913
81,690 Added 349.24%
105,081 $1.12 Million
Q1 2024

May 15, 2024

BUY
$11.27 - $13.53 $263,616 - $316,480
23,391 New
23,391 $279,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.